Literature DB >> 24748118

Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.

Sebastian Brandner1, Christian Thaler1, Natalia Lelental2, Michael Buchfelder1, Andrea Kleindienst1, Juan Manuel Maler2, Johannes Kornhuber2, Piotr Lewczuk2.   

Abstract

BACKGROUND: Little information is available on the rostro-caudal concentration gradient of Alzheimer's disease (AD) biomarkers.
OBJECTIVE: We studied the concentrations of amyloid-β (Aβ) peptides 1-42 and 1-40 as well as the Tau and pTau proteins in simultaneously collected ventricular and lumbar cerebrospinal fluid (CSF) samples.
METHODS: The samples were simultaneously collected from the ventricle and the lumbar spinal canal in two groups of patients: 10 subjects being treated for normal pressure hydrocephalus (NPH) by the placement of a ventriculo-peritoneal shunt and 5 patients treated simultaneously with an external ventricular drain and a lumbar CSF drain due to posttraumatic hydrocephalus (PTH).
RESULTS: The ventricular-lumbar (V/L) concentration ratio for Aβ1-40 was 0.81 in NPH patients and 0.71 in PTH patients. The V/L-ratio for Aβ1-42 was 0.84 in NPH, reflecting significantly higher concentrations in lumbar CSF than in ventricular CSF, and 1.02 in PTH patients. The V/L-ratios for Tau and pTau differed significantly depending on the diagnostic group: the median V/L-ratio for Tau was 6.83 in NPH patients but only 0.97 in PTH patients. The median V/L-ratio for pTau was 2.36 in NPH patients and 0.91 in PTH patients.
CONCLUSIONS: We conclude that the rostro-caudal concentration gradient for brain-derived proteins (Tau and pTau in this study) depends on the diagnosis and clinical status of the patient, which were largely neglected in the previously postulated models.

Entities:  

Keywords:  Amyloid-β; biomarker; cerebrospinal fluid; rostro-caudal gradient; tau

Mesh:

Substances:

Year:  2014        PMID: 24748118     DOI: 10.3233/JAD-132708

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

1.  Cerebrospinal fluid osmolality cannot predict development or surgical outcome of idiopathic normal pressure hydrocephalus.

Authors:  Eva Kjer Oernbo; Annette Buur Steffensen; Hanne Gredal; Helle Harding Poulsen; Nina Rostgaard; Cecilie Holm Rasmussen; Marlene Møller-Nissen; Anja Hviid Simonsen; Steen Gregers Hasselbalch; Marianne Juhler; Nanna MacAulay
Journal:  Fluids Barriers CNS       Date:  2022-06-27

2.  Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.

Authors:  Sara Hall; Christina D Orrù; Byron Caughey; Oskar Hansson; Geidy E Serrano; Douglas Galasko; Andrew G Hughson; Bradley R Groveman; Charles H Adler; Thomas G Beach
Journal:  Acta Neuropathol Commun       Date:  2022-06-22       Impact factor: 7.578

3.  Lumbar Cerebrospinal Fluid Biomarkers of Posthemorrhagic Hydrocephalus of Prematurity: Amyloid Precursor Protein, Soluble Amyloid Precursor Protein α, and L1 Cell Adhesion Molecule.

Authors:  Diego M Morales; Shawgi A Silver; Clinton D Morgan; Deanna Mercer; Terri E Inder; David M Holtzman; Michael J Wallendorf; Rakesh Rao; James P McAllister; David D Limbrick
Journal:  Neurosurgery       Date:  2017-01-01       Impact factor: 4.654

Review 4.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

5.  Tract-Specific Relationships Between Cerebrospinal Fluid Biomarkers and Periventricular White Matter in Posthemorrhagic Hydrocephalus of Prematurity.

Authors:  Diego M Morales; Christopher D Smyser; Rowland H Han; Jeanette K Kenley; Joshua S Shimony; Tara A Smyser; Jennifer M Strahle; Terrie E Inder; David D Limbrick
Journal:  Neurosurgery       Date:  2021-02-16       Impact factor: 4.654

6.  Small cisterno-lumbar gradient of phosphorylated Tau protein in geriatric patients with suspected normal pressure hydrocephalus.

Authors:  Marija Djukic; Annette Spreer; Peter Lange; Stephanie Bunkowski; Jens Wiltfang; Roland Nau
Journal:  Fluids Barriers CNS       Date:  2016-08-31

7.  No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.

Authors:  Claudia Cicognola; Davide Chiasserini; Paolo Eusebi; Ulf Andreasson; Hugo Vanderstichele; Henrik Zetterberg; Lucilla Parnetti; Kaj Blennow
Journal:  Mol Neurodegener       Date:  2016-09-07       Impact factor: 14.195

8.  Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.

Authors:  Naoto Jingami; Kengo Uemura; Megumi Asada-Utsugi; Akira Kuzuya; Shigeki Yamada; Masatsune Ishikawa; Takashi Kawahara; Takuya Iwasaki; Masamichi Atsuchi; Ryosuke Takahashi; Ayae Kinoshita
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 9.  Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted Approaches.

Authors:  Douglas Galasko
Journal:  Front Neurol       Date:  2015-12-16       Impact factor: 4.003

10.  The Connected Steady State Model and the Interdependence of the CSF Proteome and CSF Flow Characteristics.

Authors:  Fabian Metzger; Daniel Mischek; Frédéric Stoffers
Journal:  Front Neurosci       Date:  2017-05-19       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.